VA Stops Using Roche's Avastin For Eye Disease - Sept. 22, 2011

Having trouble viewing this email? View in Browser.

Thursday, September 22, 2011  |   |   |   |  At Aptuit's MHRA certified and FDA inspected multi-purpose manufacturing site in Oxford, England, we can produce highly potent compounds at commercial scale in accordance with the highest safety and quality standards. Please click here for more information. •  VA Stops Using Roche (RHHBY)'s Avastin for Eye Disease More... More Discontinuations News More Recalls and Warning News •  New Research Challenges Sirtris Pharmaceuticals (SIRT)'s Longevity Gene Findings More... •  OncoGenex Pharmaceuticals Inc. Release: A Phase III Clinical Trial Testing Long-Term Pain Management in Men With Metastatic Castrate-Resistant Prostate Cancer is Open and Enrolling More... •  Trophos Announces Final Patient Completion of Pivotal Phase 3 Efficacy Study of Olesoxime in Amyotrophic Lateral Sclerosis (ALS, Or Lou Gehrig's Disease) More... •  Pfizer Inc. (PFE) Release: New Phase 3 Safety Data For Bazedoxifene/Conjugated Estrogens, An Investigational Therapy Being Studied For The Treatment Of Menopausal Symptoms, Show Less Than One Percent Incidence Of Endometrial Hyperplasia More... •  Boehringer Ingelheim Pharmaceuticals, Inc. Release: New Study Published in The New England Journal of Medicine Shows Investigational BIBF 1120 Demonstrated Positive Trend in Reducing Lung Function Loss in Idiopathic Pulmonary Fibrosis More... More Phase III News More Phase II News More Phase I News More Pre-Clinical News More Post-Approval News Drug Discovery & Development Drug Discovery & Development magazine delivers vital insight about the latest technologies and tools used to develop pharmaceutical products to key decision-makers Request Now! •  Do Women's Voices Really Allow Men to Detect Ovulation? Roehampton University and Tel Aviv University Study More... •  Could Divorce Trigger Hair Loss in Women? Case Western Reserve University Study More... •  Lung Cancer Linked to Risk of Stroke, Harvard School of Public Health Study More... •  First Anti-Wrinkle Pill Shows Signs of Success, Unilever (UN) Study More... •  Gene Activity May Predict Trauma Outcome, Princeton University Study More... More General Clinical Research News Social & Scientific Systems, Inc., and panel members, Eleanor Feingold, Gina D'Angelo, and Joan Bailey-Wilson, invite you to join us at a symposium to honor Brad Efron for his many contributions to theoretical and applied statistics. We will be discussing emerging statistical challenges in large-scale inference, with a focus on applications in genetics and biomedical imaging. The goal of the symposium is to stimulate discussion; it will include both formal and informal meeting and discussion time, in addition to the featured speakers. The symposium is limited to 200 people. Please RSVP to: LargeData@s-3.com. Please visit here for more information. Market and Product Forecasts: Depression - Pipeline set to rejuvenate saturated market • Access Datamonitor's patient-based depression market forecast in the seven major markets, with transparent methodology and clear assumptions. • Evaluate a highly granular forecast with sales value and volume projections to 2020 at the country, class, product, and regimen level. • Understand depression market dynamics, and which factors will lead to commercial success. Click Here for More Information. • Pharm Country (Bridgewater, New Jersey) Aerie Pharmaceuticals Clinical Research Associate Travel to investigational sites to review CRF data for clinical studies. Assist with data query resolution.Perform study drug accountability. Maintain regulatory document files. Assist in development of: project plan, reference manual, study binder, CRF guidelines, transmittal/accountability forms. • BioMidwest (Chicago, Illinois) Takeda Pharmaceuticals Clinical Trial Manager / Sr. Clinical Trial Manager, Clinical Program Management Responsible for the execution of Phase II - IV and other approved US and ex-US clinical studies, according to ICH-GCP and required regional regulations as applicable in support of the clinical strategies defined in the Takeda Integrated Development Plan Responsible for the execution of Phase II-IV and other (IDP). • BioCapital (Gaithersbug, Maryland) MedImmune, LLC Associate Director, Clinical Development Create and maintain the CDP for assigned programs ensuring alignment with the Target Product Profile (TPP), accounting for feasibility and regional requirements, capturing health outcomes, epidemiology, and pharmacogenetic considerations. May have a leadership role on clinical teams for assigned programs/projects and may be a representative on the (PDT). Supervise/mentor/advise clinical project team and sub-team members in planning, conducting, data review and cleaning, and evaluating clinical trials. • SuisseBio (Basel, Switzerland) Novartis Institutes for BioMedical Research, Inc. MD Clinical Pharmacologist Autoimmunity Director (Snr TMEI Profiling) Develop strategies, design and execute clinical trials from Proof of Concept to Phase II/III, registration and beyond for new drugs. Represent and champion our compounds internally and with regulatory authorities. • Biotech Beach (Westlake Village, California) Baxter International, Inc. Senior Clinical Project Coordinator Assist Management (i.e., Clinical Project Managers, Managers of Clinical Operations) of Clinical Operations with the day-to-day activities that support clinical trials conducted for new product license applications, for line extensions of existing products, and for post-marketing commitments to Regulatory Authorities. • Get Noticed! Add your resume to the BioSpace Career Center! • See more than 5,000 job postings in the BioSpace Career Center! Biotech Beach Career Fair Job seekers can spend a day with HR representatives and Hiring Managers from top biotech, pharma, medical device and diagnostics companies in the Southern California region. Candidates with a 4-year degree in the life sciences and a minimum of 2-years of industry related experience are invited to attend. (Equivalent work experience may be considered in lieu of a four-year college degree. PhD and Postdoc candidates welcome.) Exhibiting companies are recruiting for positions in areas such as: QA/QC, clinical research, engineering, manufacturing, biostatistics, clinical data management, chemistry, regulatory affairs, and research. Job seekers may register here. • Biotech Beach Career Fair, San Diego, CA September 22, 2011 • BioMidwest Career Fair, Chicago, IL October 4, 2011 • Pharm Country Career Fair, Bridgewater, NJ October 5, 2011 • Biotech Bay Career Fair, Burlingame, CA October 11, 2011 • Bio NC Career Fair, Durham, NC October 20, 2011 • BioCapital Beach Career Fair, Bethesda, MD November 1, 2011 • Genetown Career Fair, Cambridge, MA November 7, 2011 More information about BioSpace's Career Fairs BioSpace White Paper Biotech Career Fairs For Job Seekers 101: Control Your Experience By June Salvati, BioSpace Director of Events and Corporate Services •  Accelr8 Technology Corporation (AXK) Announces Renewal and Expansion of SCHOTT Microarray License, and Notice of Allowance for New Patent More... •  VIRxSYS Corporation Issued Third U.S. Patent This Year for its Spliceosome-Mediated RNA Trans-Splicing (SMaRT(TM)) Program; Breakthrough RNA Therapeutic Platform More... •  Adamis Pharmaceuticals Prostate Cancer Drug APC-200 Granted Patents in Singapore and South Africa More... •  Lixte Biotechnology Announces Issuance of U.S. Patent for Lead Anti-Cancer Compound More... More Patent News •  A Controversial Bayer Corporation (BAY) Drug Returns to Canada More... •  Dr. Reddy's Laboratories Ltd. (RDY)'s Announces the Launch of Rivastigmine Tartrate Capsules More... More Drug Product News Hot Company Purdue Pharma L.P. (Research & Development - New Jersey) 6 Cedar Brook Drive Cranbury, New Jersey 08512 U.S.A. Phone: 609-409-5123 Fax: 609-409-5799 Purdue Pharma is committed to developing safe and effective medicines to treat pain and other conditions. As a science-based company, we are discovering drugs with new mechanisms of action and exploring new techniques in drug delivery to enhance the effectiveness and safety of drug therapy. More Company Profiles Post Your: News | Jobs | Company Profile | Event | Advertising / Sponsorship ClinicaSpace 6465 South Greenwood Plaza, Suite 400 Centennial, Colorado 80111 U.S.A. Phone: 877-277-7585 Fax: 800-595-2929 ClinicaSpace 90 New Montgomery Street, Suite 414 San Francisco, California 94105 U.S.A. Phone: 877-277-7585 Fax: 415-576-9217 Send questions and comments to the ClinicaSpace News Beat Team. Editor & Publisher: Rosemary Do Editorial & Production Staff: Lana Ho, Suvarna Sheth, Maysa Darwish, Tammy Liu ClinicaSpace.com - Clinical Trials. Clinical Research. Community. • ClinicaSpace is a registered trademark of BioSpace, Inc. • Please distribute this e-cast freely. • Credit any excerpts as follows: Copyright 2011 ClinicaSpace http://www.clinicaspace.com • While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes. If someone forwarded this news to you and you'd like to receive your own copy FREE of charge, simply Subscribe here. Safely unsubscribe from ClinicaSpace.com e-mail at any time by managing your account here.